The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCyanconnode Regulatory News (CYAN)

Share Price Information for Cyanconnode (CYAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.30
Bid: 8.20
Ask: 8.40
Change: -0.10 (-1.19%)
Spread: 0.20 (2.439%)
Open: 8.40
High: 8.40
Low: 8.30
Prev. Close: 8.40
CYAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

9 Nov 2016 07:00

RNS Number : 6773O
Cyan Holdings Plc
09 November 2016
 

 

 

Cyan Holdings plc("CyanConnode" or the "Group")

 

Issue of Equity

CyanConnode (AIM: CYAN.L), the world leader in narrowband RF networks for Omni IoT communications is pleased to announce that Nightingale Investment Company Limited ("Nightingale"), Fataarc Limited ("Fataarc") and other existing shareholders have agreed to invest a further £1,210,000 in the Group by way of a subscription for 605,000,000 ordinary shares of 0.01 pence each ("Subscription Shares") at a price of 0.2p per Subscription Share (the "Subscription").

 

Biggles Enterprises Limited ("Biggles") and Fataarc have together invested £3,050,000 into CyanConnode equity in June and October 2016. Nightingale and Fataarc (which are associated with Biggles) have now agreed to invest a further £1,050,000.

 

The investments are being made by way of a subscription for 605,000,000 Subscription Shares at a price of 0.20 pence per share (the "Issue Price"). The Issue Price represents a premium of 11.1% to the last investment made by Biggles and Fataarc on 3 October 2016 at a price of 0.18 pence per share. The Issue Price represents a discount of 2.4 per cent. to the Group's mid-market closing price on 8 November 2016, being the last business day prior to the publication of this announcement.

 

The Subscription has been undertaken pursuant to the general authorities granted to the board of directors at the general meeting of the Group held on 30 June 2016 and therefore no further shareholder approval is required. The Subscription is not underwritten and is conditional only upon admission of the Subscription Shares to trading on AIM. Application will be made for the admission of the Subscription Shares to trading on AIM and it is expected that the Subscription Shares will be admitted to trading on AIM at 8.00 a.m. on 14 November 2016 ("Admission"). The Subscription Shares will be issued credited as fully paid and will rank pari passu in all respects with the Group's existing ordinary shares of 0.01 pence each. The Subscription Shares are not being made available to the public and are not being offered or sold in or into any jurisdiction where it would be unlawful to do so.

 

Related Party Transaction

 

John Stamp is a substantial shareholder of the Company, being interested in 11.04 per cent of the Company's share capital through Biggles. Nightingale (being an associate company of John Stamp) constitutes a related party of the Group and its participation in the Subscription is considered a related party transaction under the AIM Rules for Companies. The Directors of CyanConnode, having consulted with the Group's nominated adviser, Cantor Fitzgerald Europe, consider that the terms of Nightingale's investment are fair and reasonable insofar as the Group's shareholders are concerned.

 

Following Admission, John Stamp will be interested in 2,166,666,666 ordinary shares of 0.01 pence each, representing 13.80 per cent of the Company's issued share capital.

 

Total Voting Rights

 

Following Admission, the Group's total issued share capital will be 15,702,667,349 ordinary shares of 0.01 pence each. This figure may be used by shareholders as the denominator by which they will determine if they are required to notify their interest in, or a change to their interest in, the Group under the Disclosure and Transparency Rules.

 

John Cronin, Executive Chairman of Cyan, commented:

 

"I was delighted to be approached by Nightingale and Fataarc wishing to make an investment in CyanConnode, as well as other existing shareholders, and the Group is very appreciative of their continued support."

 

The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). This inside information is now considered to be in the public domain.

 

Enquiries:

 

Cyan Holdings plc

Tel: +44 (0) 1223 225060

John Cronin, Executive Chairman

www.cyanconnode.com

Cantor Fitzgerald Europe - Nomad and Broker

Tel: +44 20 7894 7000

Andrew Craig / Richard Salmond

Beaufort Securities Limited - Joint Broker

Tel: +44 (0) 20 7382 8300

Jon Belliss

Walbrook PR - Financial PR

Tel: +44(0) 20 7933 8780

Paul Cornelius/Nick Rome

 

cyanconnode@walbrookpr.com

About CyanConnode

 

CyanConnode is a world leader in narrowband RF mesh networks that enable Omni IoT communications. Cyan's Ultimesh provides narrowband RF mesh network, optimised for exceptional performance and total cost of ownership and Connode's Panmesh delivers standards-based IPv6 solutions, enabling rapid innovation for the implementation of 3rd party applications. The Group provides customers with the flexibility and choice required to converge networks for applications in smart cities and IoT, delivering increased customer value.

 

For more information, please visit www.cyanconnode.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEAKFDDFBDDPDK
Date   Source Headline
18th Apr 20247:00 amRNSAppointment of Joint Broker
17th Apr 20241:56 pmRNSHolding(s) in Company
16th Apr 20247:00 amRNSTrading Update
15th Apr 20247:00 amRNSOrder For A New Deployment In India
12th Apr 20247:00 amRNSMiddle East Energy Leadership Summit 2024
15th Jan 20247:00 amRNSAppointment of Non-Executive Director
11th Jan 20247:00 amRNSOrder For One Million Omnimesh Modules
27th Dec 20234:18 pmRNSDirector Dealing
19th Dec 20237:00 amRNSInterim Results
6th Dec 20231:32 pmRNSChange of Registered Office
1st Dec 20234:18 pmRNSHolding(s) in Company
21st Nov 20232:31 pmRNSHolding(s) in Company
20th Nov 20236:14 pmRNSIssue of Share Options – Correction
20th Nov 20237:00 amRNSNamed as One of the Fastest Growing Companies
17th Nov 20233:45 pmRNSDirector Option Grants
17th Nov 20238:30 amRNSHolding(s) in Company
16th Nov 202312:48 pmRNSHolding(s) in Company
15th Nov 20237:00 amRNSRanked 2nd Fastest-Growing UK Company in India
13th Nov 20236:11 pmRNSPlacing and Subscription – update
9th Nov 20238:02 amRNSResult of Oversubscribed Placing and Subscription
8th Nov 20235:24 pmRNSProposed Placing and Subscription to Raise c.£2.5m
31st Oct 20237:15 amRNSContract in the Middle East and North Africa
10th Oct 20237:00 amRNSOrder for 300,000 Omnimesh Modules
5th Oct 20237:00 amRNSTrading Update
24th Aug 202312:18 pmRNSResult of AGM
17th Aug 20231:00 pmRNSHolding(s) in Company
15th Aug 20237:00 amRNS2023 Annual General Meeting
4th Aug 20235:34 pmRNSDirector Dealing
2nd Aug 20237:00 amRNSOrder for 300,000 Omnimesh Modules
26th Jul 20235:34 pmRNSCorrection: Final Results
26th Jul 20237:00 amRNSFinal Results
25th Jul 20237:00 amRNSNotice of Results & Investor Presentation
6th Jul 20237:00 amRNSTrading Update
22nd Jun 20237:00 amRNSCyanConnode India is a Start-Up 50 Trailblazer
25th May 20238:10 amRNSOrder for 600,000 Omnimesh Modules
9th May 20233:45 pmRNSHolding(s) in Company
17th Apr 20237:00 amRNSInterview with MD & CEO for CyanConnode India
3rd Apr 20237:00 amRNSCyanConnode and Alfanar Sign MOU for AMI projects
21st Mar 20237:15 amRNSHardman Research - Acceleration and revenue uplift
13th Mar 20237:00 amRNSCyanConnode Banking Arrangements
7th Mar 20237:00 amRNSCollaboration with Silicon Laboratories
6th Mar 20237:00 amRNSAppointment of Nominated and Financial Adviser
6th Feb 20238:51 amRNSStrategic Framework Agreement - Replacement
6th Feb 20238:21 amRNSStrategic Framework Agreement
6th Feb 20237:00 amRNSStrategic Framework Agreement
31st Jan 20237:00 amRNSHolding(s) in Company
24th Jan 20238:00 amRNSResult of Oversubscribed Placing and Subscription
23rd Jan 20235:11 pmRNSProposed Placing and Subscription
19th Jan 20237:00 amRNSChange of Adviser
4th Jan 20237:00 amRNSOrder From New Partner

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.